Risk factors of chronic kidney diseases in Chinese adults with type 2 diabetes
暂无分享,去创建一个
L. Yang | H. Nan | J. Lian | Jun Liang | Tsun Kit Chu | C. Lo | Pak Ki Lau
[1] Jackson T. Wright,et al. 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. , 2018, Journal of the American College of Cardiology.
[2] Douglas E Schaubel,et al. US Renal Data System 2017 Annual Data Report: Epidemiology of Kidney Disease in the United States. , 2018, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[3] Wilbert S Aronow,et al. 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. , 2017, Journal of the American College of Cardiology.
[4] E. Wan,et al. Prediction of new onset of end stage renal disease in Chinese patients with type 2 diabetes mellitus – a population-based retrospective cohort study , 2017, BMC Nephrology.
[5] J. Chan,et al. Declining Trends of Cardiovascular-Renal Complications and Mortality in Type 2 Diabetes: The Hong Kong Diabetes Database , 2017, Diabetes Care.
[6] Douglas E Schaubel,et al. US Renal Data System 2016 Annual Data Report: Epidemiology of Kidney Disease in the United States. , 2017, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[7] X. Ji,et al. Association of Chronic Kidney Disease with Coronary Heart Disease and Stroke Risks in Patients with Type 2 Diabetes Mellitus: An Observational Cross-sectional Study in Hangzhou, China , 2017, Chinese medical journal.
[8] E. Wan,et al. Effectiveness of a multidisciplinary risk assessment and management programme—diabetes mellitus (RAMP-DM) on patient-reported outcomes , 2017, Endocrine.
[9] Y. Bao,et al. Prevalence of chronic kidney disease and associated factors in Chinese individuals with type 2 diabetes: Cross-sectional study. , 2016, Journal of diabetes and its complications.
[10] E. Wan,et al. Incidence and predictors for cardiovascular disease in Chinese patients with type 2 diabetes mellitus - a population-based retrospective cohort study. , 2016, Journal of diabetes and its complications.
[11] M. Halim,et al. Diabetic kidney disease: world wide difference of prevalence and risk factors , 2015, Journal of nephropharmacology.
[12] M. Harrison. A Global Perspective , 2015, Bulletin of the history of medicine.
[13] R. Boston,et al. The Chronic Kidney Disease-Epidemiology Collaboration (CKD-EPI) equation does not improve the underestimation of Glomerular Filtration Rate (GFR) in people with diabetes and preserved renal function , 2015, BMC Nephrology.
[14] R. Ozaki,et al. The Clinical Utility of SUDOSCAN in Chronic Kidney Disease in Chinese Patients with Type 2 Diabetes , 2015, PloS one.
[15] Alan B Leichtman,et al. US Renal Data System 2014 Annual Data Report: Epidemiology of Kidney Disease in the United States. , 2015, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[16] A. Levey,et al. Glomerular filtration rate and albuminuria for detection and staging of acute and chronic kidney disease in adults: a systematic review. , 2015, JAMA.
[17] C. Fung,et al. Effects of the Multidisciplinary Risk Assessment and Management Program for Patients with Diabetes Mellitus (RAMP-DM) on biomedical outcomes, observed cardiovascular events and cardiovascular risks in primary care: a longitudinal comparative study , 2014, Cardiovascular Diabetology.
[18] F. Kronenberg,et al. Associations of estimated glomerular filtration rate and albuminuria with mortality and renal failure by sex: a meta-analysis , 2013, BMJ.
[19] Eva L. H. Tsui,et al. Evaluation of the quality of care of a multi-disciplinary risk factor assessment and management programme (RAMP) for diabetic patients , 2012, BMC Family Practice.
[20] J. Chan,et al. Chronic Kidney Disease and Associated Cardiovascular Risk Factors in Chinese with Type 2 Diabetes , 2012, Diabetes & metabolism journal.
[21] E. Mohammadi,et al. Barriers and facilitators related to the implementation of a physiological track and trigger system: A systematic review of the qualitative evidence , 2017, International journal for quality in health care : journal of the International Society for Quality in Health Care.
[22] Patrick J Heagerty,et al. Temporal trends in the prevalence of diabetic kidney disease in the United States. , 2011, JAMA.
[23] K. Xiang,et al. Prevalence and risk factors of albuminuria and chronic kidney disease in Chinese population with type 2 diabetes and impaired glucose regulation: Shanghai diabetic complications study (SHDCS). , 2009, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[24] R. MacIsaac,et al. Integrating albuminuria and GFR in the assessment of diabetic nephropathy , 2009, Nature Reviews Nephrology.
[25] M. Hsieh,et al. Chronic Kidney Disease as a Risk Factor for Coronary Artery Disease in Chinese with Type 2 Diabetes , 2007, American Journal of Nephrology.
[26] Song-min Huang,et al. Modified glomerular filtration rate estimating equation for Chinese patients with chronic kidney disease. , 2006, Journal of the American Society of Nephrology : JASN.
[27] A. Kong,et al. End-stage renal disease risk equations for Hong Kong Chinese patients with type 2 diabetes: Hong Kong Diabetes Registry , 2006, Diabetologia.
[28] H. Parving,et al. Prevalence and risk factors for microalbuminuria in a referred cohort of type II diabetic patients: a global perspective. , 2006, Kidney international.
[29] Robert M Califf,et al. Relation between renal dysfunction and cardiovascular outcomes after myocardial infarction. , 2004, The New England journal of medicine.
[30] Bertram L Kasiske,et al. Kidney disease as a risk factor for development of cardiovascular disease: a statement from the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention. , 2003, Hypertension.